| Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin B Pang, X Qiao, L Janssen, A Velds, T Groothuis, R Kerkhoven, ... Nature communications 4 (1), 1908, 2013 | 405 | 2013 |
| Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics RH Wijdeven, B Pang, YG Assaraf, J Neefjes Drug Resistance Updates 28, 65-81, 2016 | 172 | 2016 |
| Gap junction-mediated intercellular communication in the immune system J Neijssen, B Pang, J Neefjes Progress in biophysics and molecular biology 94 (1-2), 207-218, 2007 | 131 | 2007 |
| Systematic identification of silencers in human cells B Pang, MP Snyder Nature genetics 52 (3), 254-263, 2020 | 118 | 2020 |
| Uncoupling DNA damage from chromatin damage to detoxify doxorubicin X Qiao, SY van der Zanden, DPA Wander, DM Borràs, JY Song, X Li, ... Proceedings of the National Academy of Sciences 117 (26), 15182-15192, 2020 | 107 | 2020 |
| Genome-wide identification and characterization of novel factors conferring resistance to topoisomerase II poisons in cancer RH Wijdeven, B Pang, SY van der Zanden, X Qiao, V Blomen, ... Cancer research 75 (19), 4176-4187, 2015 | 102 | 2015 |
| Direct antigen presentation and gap junction mediated cross-presentation during apoptosis B Pang, J Neijssen, X Qiao, L Janssen, H Janssen, C Lippuner, J Neefjes The Journal of Immunology 183 (2), 1083-1090, 2009 | 88 | 2009 |
| Chemical profiling of the genome with anti-cancer drugs defines target specificities B Pang, J De Jong, X Qiao, LFA Wessels, J Neefjes Nature chemical biology 11 (7), 472-480, 2015 | 79 | 2015 |
| Methylation-associated silencing of BASP1 contributes to leukemogenesis in t (8; 21) acute myeloid leukemia L Zhou, L Fu, N Lv, J Liu, Y Li, X Chen, Q Xu, G Chen, B Pang, L Wang, ... Experimental & molecular medicine 50 (4), 1-8, 2018 | 37 | 2018 |
| Gap junction communication between autologous endothelial and tumor cells induce cross-recognition and elimination by specific CTL H Benlalam, A Jalil, M Hasmim, B Pang, R Tamouza, M Mitterrand, ... The Journal of Immunology 182 (5), 2654-2664, 2009 | 37 | 2009 |
| Identification of non-coding silencer elements and their regulation of gene expression B Pang, JH van Weerd, FL Hamoen, MP Snyder Nature Reviews Molecular Cell Biology 24 (6), 383-395, 2023 | 18 | 2023 |
| Association of AHSG with alopecia and mental retardation (APMR) syndrome M Reza Sailani, F Jahanbani, J Nasiri, M Behnam, M Salehi, M Sedghi, ... Human genetics 136, 287-296, 2017 | 14 | 2017 |
| Coupled for cross-presentation in tumor immunotherapy B Pang, J Neefjes Science Translational Medicine 2 (44), 44ps40-44ps40, 2010 | 10 | 2010 |
| Targeted CRISPR activation and knockout screenings identify novel doxorubicin transporters Y Li, M Tan, S Sun, E Stea, B Pang Cellular Oncology, 1-14, 2023 | 1 | 2023 |
| Targeted CRISPR activation and knockout screenings identify novel drug transporters Y Li, M Tan, S Sun, E Stea, B Pang | | 2023 |
| Systems and Methods to Identify Genetic Silencers and Applications Thereof B Pang, MP Snyder US Patent App. 17/759,917, 2023 | | 2023 |
| Diverging the anthracycline class of anti-cancer drugs for superior survival of acute myeloid leukemia patients X Qiao, S van der Zanden, X Li, M Tan, Y Zhang, JY Song, M van Gelder, ... medRxiv, 2023.11. 23.23298950, 2023 | | 2023 |
| New factors in the control of antigen presentation by MHC class I and II proteins J Neefjes, R Wijdeven, B Pang, I Berlin, P Perrin, B Cabukusta, ... Molecular Immunology 150, 17, 2022 | | 2022 |
| Weerd BX Pang H. an, Hamoen, FL, & Sn der, MP, 2022 | | 2022 |
| Exploring the chemical space around the 3’amine of doxorubicin for improved cytotoxic drugs with different genomic specificity SY van der Zanden, FL Hamoen, D Borràs, DPA Wander, HS Overkleeft, ... Novel insights into old anticancer drugs, 163, 2021 | | 2021 |
